Effect of cloretazine on acute myeloid leukaemia blasts in vitro as a single agent and combined with cytarabine and daunorubicin

被引：0
|
作者：
Morris, K. [1 ]
Wren, D. [1 ]
Adams, J. A. [1 ]
Yin, J. A. Liu [1 ]
机构：
[1] Manchester Royal Infirm, Manchester M13 9WL, Lancs, England
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1120
引用
收藏
页码：412 / 412
页数：1
相关论文
共 50 条
  • [21] Detection of Cup-like Blasts in Acute Myeloid Leukaemia
    Mehrotra, Supriya
    Singh, Priyanka
    Srivastava, Rajesh Kumar
    Kapoor, A. K.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2019, 13 (10)
  • [22] Genes and Mechanisms Responsible for Expansion of Acute Myeloid Leukaemia Blasts
    Dvorak, M.
    Dvorakova, M.
    FOLIA BIOLOGICA, 2019, 65 (01) : 11 - 23
  • [23] Single agent thalidomide in patients with relapsed or refractory acute myeloid leukaemia
    Thomas, DA
    Estey, E
    Giles, FJ
    Faderl, S
    Cortes, J
    Keating, M
    O'Brien, S
    Albitar, M
    Kantarjian, H
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 123 (03) : 436 - 441
  • [24] Venetoclax Combined with Daunorubicin and Cytarabine (DAV) As Induction Therapy in De Novo Young Adult Acute Myeloid Leukemia
    Wang, Huafeng
    Mao, Liping
    Xie, Wanzhuo
    Tong, Hongyan
    Yang, Min
    Xu, Gaixiang
    Ye, Xiujin
    Lu, Ying
    Wei, Juying
    Mai, Wenyuan
    Zhou, De
    Jin, Jie
    Zhu, Hong-Hu
    BLOOD, 2021, 138
  • [25] Azacitidine Combined with Homoharringtonine, Idarubicin/Daunorubicin, Cytarabine for Previously Untreated Patients with Acute Myeloid Leukemia: A Single-Center, Phase 2 Study
    Li, Jun
    Huang, Yanqing
    Hou, Yue
    Zi, Jie
    Song, Chunhua
    Ge, Zheng
    BLOOD, 2022, 140 : 3273 - 3274
  • [26] Ultraviolet recall due to cytarabine chemotherapy for acute myeloid leukaemia
    Kuo, Dennis John
    Spies, Jeanie Marie
    Le Floch, Nathalie
    Wong, Victor
    BMJ CASE REPORTS, 2021, 14 (11)
  • [27] In vitro resistance to cytosine arabinoside, not to daunorubicin, is associated with the risk of relapse in de novo acute myeloid leukaemia
    Klumper, E
    Ossenkoppele, GJ
    Pieters, R
    Huismans, DR
    Loonen, AH
    Rottier, A
    Westra, G
    Veerman, AJP
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 (04) : 903 - 910
  • [28] Peripheral blood stem cell harvesting using single agent cytarabine and GCSF in Asian patients with acute myeloid leukaemia at our institution
    Soh, T.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S309 - S309
  • [29] Phase I study of alvocidib plus cytarabine/mitoxantrone or cytarabine/daunorubicin for acute myeloid leukemia in Japan
    Ikezoe, Takayuki
    Ando, Kiyoshi
    Onozawa, Masahiro
    Yamane, Takahisa
    Hosono, Naoko
    Morita, Yasuyoshi
    Kiguchi, Toru
    Iwasaki, Hiromi
    Miyamoto, Toshihiro
    Matsubara, Keisuke
    Sugimoto, Saori
    Miyazaki, Yasushi
    Kizaki, Masahiro
    Akashi, Koichi
    CANCER SCIENCE, 2022, 113 (12) : 4258 - 4266
  • [30] Liposomal cytarabine and daunorubicin (CPX-351) for treatment of acute myeloid leukemia
    Ronson, Aaron
    Tvito, Ariella
    Rowe, Jacob M.
    EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (04): : 369 - 374
12345